Role of PYK2 in the development of obesity and insulin resistance

Biochemical and Biophysical Research Communications

Volumn 334, Issue 4, 2005, Pages 1085-1091

  Yu, Ying ^a   Ross, Stuart A ^a,b   Halseth, Amy E ^a,c   Hollenbach, Paul W ^a,d   Hill, Ronald J ^a,e   Gulve, Eric A ^a   Bond, Brian R ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b The Institute for Diabetes Discovery   (United States)

^c AMYLIN PHARMACEUTICALS INC   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e ROCHE BIOSCIENCE   (United States)

Author keywords

Knockout; Obesity; PYK2

Indexed keywords

FAT; FOCAL ADHESION KINASE 2; GLUCOSE; INSULIN; LEPTIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL DIET; CONTROLLED STUDY; DIABETIC OBESITY; ENZYME REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SPECIES COMPARISON; WEIGHT GAIN; WILD TYPE;

ANIMALS; BODY WEIGHT; DIETARY FATS; FOCAL ADHESION KINASE 2; GLUCOSE; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; OBESITY; ORGAN SPECIFICITY; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; TISSUE DISTRIBUTION;

EID: 23044510550     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.06.198     Document Type: Article

References (36)

1. S.A. Ross, E.A. Gulve, and M. Wang Chemistry and biochemistry of type 2 diabetes Chem. Rev. 104 2004 1255 1282
2. P.M. Sharma, K. Egawa, Y. Huang, J.L. Martin, I. Huvar, G.R. Boss, and J.M. Olefsky Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action J. Biol. Chem. 273 1998 18528 18537
3. B. Cheatham, C. Vlahos, L. Cheatham, L. Wang, J. Blenis, and C.R. Kahn Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation Mol. Cell. Biol. 14 1994 4902 4911
4. T. Okada, Y. Kawano, T. Sakakibara, O. Hazeki, and M. Ui Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin J. Biol. Chem. 269 1994 3568 3673
5. J.I. Yeh, E.A. Gulve, L. Rameh, and M.J. Birnbaum The effects of wortmannin on rat skeletal muscle J. Biol. Chem. 270 1995 2107 2111
6. J.R. Wu-Wong, C.E. Berg, J. Wang, W.J. Chiou, and B. Fissel Endothelin stimulates glucose uptake and GLUT4 translocation via activation of endothelin ETA receptor in 3T3-L1 adipocytes J. Biol. Chem. 274 1999 8103 8110
7. T. Imamura, K. Ishibashi, S. Dalle, S. Ugi, and J.M. Olefsky Endothelin-1-induced GLUT4 translocation is mediated via Galpha(q/11) protein and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes J. Biol. Chem. 274 1999 33691 33695
8. J.R. Wu-Wong, C.E. Berg, and D. Kramer Endothelin stimulates glucose uptake via activation of endothelin-A receptor in neonatal rat cardiomyocytes J. Cardiovasc. Pharmacol. 36 2000 S179 S183
9. J.S. Elmendorf, D. Chen, and J.E. Pessin Guanosine 5′-O-(3- thiotriphosphate) (GTPgammaS) stimulation of GLUT4 translocation is tyrosine kinase-dependent J. Biol. Chem. 273 1998 13289 13296
10. J.G. Park, A. Bose, J. Leszyk, and M.P. Czech PYK2 as a mediator of Endothelin-1/Gα 11 signaling to GLUT4 glucose transporters J. Biol. Chem. 276 2001 47751 47754
11. D. Chen, J.S. Elmendorf, A.L. Olson, X. Li, H.A. Earp, and J.E. Pessin Osmotic shock stimulates GLUT4 translocation in 3T3L1 adipocytes by a novel tyrosine kinase pathway J. Biol. Chem. 272 1997 27401 27410
12. 2+-induced regulation of ion channel and MAP kinase functions Nature 376 1995 737 745
13. M. Okigaki, C. Davis, M. Falasca, S. Harroch, D.P. Felsenfeld, M.P. Sheetz, and J. Schlessinger Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration Proc. Nat. Acad. Sci. 100 2003 10740 10745
14. K. Ishibashi, T. Imamura, P.M. Sharma, J. Huang, S. Ugi, and J.M. Olefsky Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes J. Clin. Invest. 107 2001 1193 1202
15. J.J. Wilkes, A. Hevener, and J. Olefsky Chronic endothelin-1 treatment leads to insulin resistance in vivo Diabetes 52 2003 1904 1909
16. C.C. Juan, V.S. Fang, Y.J. Huang, C.F. Kwok, Y.P. Hsu, and L.T. Ho Endothelin-1 induces insulin resistance in conscious rats Biochem. Biophys. Res. Commun. 227 1996 694 699
17. A. Ottosson-Seeberger, J.M. Lundberg, A. Alvestrand, and G. Ahlborg Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans Acta Physiol. Scand. 161 1997 211 220
18. G. Bandyopadhyay, M.P. Sajan, Y. Kanoh, M.L. Standaert, M.J. Quon, B.C. Reed, I. Dikic, and R.V. Farese Glucose activates protein kinase C-zeta/lambda through proline-rich tyrosine kinase-2, extracellular signal-regulated kinase, and phospholipase D J. Biol. Chem. 276 2001 35537 35545
19. M.P. Sajan, G. Bandyopadhyay, Y. Kanoh, M.L. Standaert, M.J. Quon, B.C. Reed, I. Dikic, and R.V. Farese Sorbitol activates atypical protein kinase C and GLUT4 glucose transporter translocation/glucose transport through proline-rich tyrosine kinase-2, the extracellular signal-regulated kinase pathway and phospholipase D Biochem. J. 362 2002 665 674
20. J.R. Sowers Insulin resistance and hypertension Am. J. Physiol. Heart Circ. Physiol. 286 2004 H1597 H1602
21. G.S. Hotamisligil The role of TNFα and TNF receptors in obesity and insulin resistance J. Intern. Med. 245 1999 621 625
22. G. Tokiwa, I. Dikic, S. Lev, and J. Schlessinger Activation of Pyk2 by stress signals and coupling with JNK signaling pathway Science 273 1996 792 794
23. M. Fuortes, M. Melchior, H. Han, G.J. Lyon, and C. Nathan Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF J. Clin. Invest. 104 1999 327 335
24. N.J. Avdi, J.A. Nick, B.B. Whitlock, M.A. Billstrom, P.M. Henson, G.L. Johnson, and G.S. Worthen Tumor necrosis factor-α activation of the c-Jun N-terminal kinase pathway in human neutrophils J. Biol. Chem. 276 2001 2189 2199
25. 2+ and PKCδ for janus kinase 2 activation by angiotensin II: involvement of pyk2 Mol. Endocrinol. 16 2002 367 377
26. 2+, PKC, and Rho kinase Am. J. Physiol. Cell Physiol. 282 2002 C1432 C1444
27. P. Rocic, H. Jo, and P.A. Lucchesi A role for PYK2 in ANG II-dependent regulation of the PHAS-1-eIF4E complex by multiple signaling cascades in vascular smooth muscle Am. J. Physiol. Cell Physiol. 285 2003 C1437 C1444
28. N. Rachdaoui, and L.E. Nagy Endothelin-1-stimulated glucose uptake is desensitized by tumor necrosis factor-α in 3T3-L1 adipocytes Am. J. Physiol. Endocrinol. Metab. 285 2003 E545 E551
29. R. Guinamard, M. Okigaki, J. Schlessinger, and J.V. Ravetch Absence of marginal zone B cells in Pyk2-deficient mice defines their role in the humoral response Nat. Immunol. 1 2000 31 35
30. R.S. Surwit, C.M. Kuhn, C. Cochrane, J.A. McCubbin, and M.N. Feinglos Diet-induced type II diabetes in C57BL/6J mice Diabetes 37 1988 1163 1167
31. S.Y. Park, H.K. Avraham, and S. Avraham RAFTK/Pyk2 activation is mediated by trans-acting autophosphorylation in a Src-independent manner J. Biol. Chem. 279 2003 33315 33322
32. A. Blaukat, I. Ivankovic-Dikic, E. Gronroos, F. Dolfi, G. Tokiwa, K. Vuori, and I. Dikic Adaptor proteins Grbs and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades J. Biol. Chem. 274 1999 14893 14901
33. R. Burcelin, V. Crivelli, A. Dacosta, A. Roy-Tirelli, and B. Thorens Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet Am. J. Physiol. Endocrinol. Metab. 282 2002 E834 E842
34. M. Maffei, J. Halaas, E. Ravussin, R.E. Pratley, G.H. Lee, Y. Zhang, H. Fei, S. Kim, R. Lallone, S. Ranganathan, P.A. Kern, and J.M. Friedman Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects Nat. Med. 1 1995 1155 1161
35. R.V. Considine, M.K. Sinha, M.L. Heiman, A. Kriaugiunas, T.W. Stephens, M.R. Nyce, J.P. Ohannesian, C.C. Marco, L.J. McKee, T.L. Bauer, and J.F. Caro Serum immunoreactive-leptin concentrations in normal-weight and obese humans N. Engl. J. Med. 334 1996 292 295
36. S. Lin, T.C. Thomas, L.H. Storlien, and X.F. Huang Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice Int. J. Obes. Relat. Metab. Disord. 24 2000 639 646